Use of artificial intelligence-powered ECG to differentiate between cardiac and pulmonary pathologies in patients with acute dyspnoea in the emergency department
Open Access
- 1 October 2024
- journal article
- research article
- Published by BMJ in Open Heart
- Vol. 11 (2) , e002924
Abstract
Background Acute dyspnoea is common in acute care settings. However, identifying the origin of dyspnoea in the emergency department (ED) is often challenging. We aimed to investigate whether our artificial intelligence (AI)-powered ECG analysis reliably distinguishes between the causes of dyspnoea and evaluate its potential as a clinical triage tool for comparing conventional heart failure diagnostic processes using natriuretic peptides. Methods A retrospective analysis was conducted using an AI-based ECG algorithm on patients ≥18 years old presenting with dyspnoea at the ED from February 2006 to September 2023. Patients were categorised into cardiac or pulmonary origin groups based on initial admission. The performance of an AI-ECG using a transformer neural network algorithm was assessed to analyse standard 12-lead ECGs for accuracy, sensitivity, specificity and area under the receiver operating characteristic curve (AUC). Additionally, we compared the diagnostic efficacy of AI-ECG models with N-terminal probrain natriuretic peptide (NT-proBNP) levels to identify cardiac origins. Results Among the 3105 patients included in the study, 1197 had cardiac-origin dyspnoea. The AI-ECG model demonstrated an AUC of 0.938 and 88.1% accuracy for cardiac-origin dyspnoea. The sensitivity, specificity and positive and negative predictive values were 93.0%, 79.5%, 89.0% and 86.4%, respectively. The F1 score was 0.828. AI-ECG demonstrated superior diagnostic performance in identifying cardiac-origin dyspnoea compared with NT-proBNP. True cardiac origin was confirmed in 96 patients in a sensitivity analysis of 129 patients with a high probability of cardiac origin initially misdiagnosed as pulmonary origin predicted by AI-ECG. Conclusions AI-ECG demonstrated superior diagnostic accuracy over NT-proBNP and showed promise as a clinical triage tool. It is a potentially valuable tool for identifying the origin of dyspnoea in emergency settings and supporting decision-making.Keywords
This publication has 22 references indexed in Scilit:
- Interpreting Black-Box Models: A Review on Explainable Artificial IntelligenceCognitive Computation, 2023
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart FailureJACC, 2022
- Artificial intelligence for the diagnosis of heart failurenpj Digital Medicine, 2020
- Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide ConcentrationsEuropean Journal of Heart Failure, 2019
- Meta-Analysis of Prognostic Implications of Dyspnea Versus Chest Pain in Patients Referred for Stress TestingThe American Journal of Cardiology, 2014
- Electrophysiological changes in heart failure and their implications for arrhythmogenesisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Clinical Utility of Three B-Type Natriuretic Peptide Assays for the Initial Diagnostic Assessment of New Slow-Onset Heart FailureJournal of Cardiac Failure, 2011
- The Diagnostic Accuracy of Plasma BNP and NTproBNP in Patients Referred From Primary Care with sUspected Heart Failure: Results of the UK Natriuretic Peptide StudyEuropean Journal of Heart Failure, 2005
- Value of natriuretic peptides in assessment of patients with possible new heart failure in primary careThe Lancet, 1997
- Learning representations by back-propagating errorsNature, 1986